Journal of Neuro-Oncology

Anti-Apoptotic Action by Hypoxia Inducible Factor 1-Alpha in Human Pituitary Adenoma Cell Line, HP-75 in Hypoxic Condition
pp. 217-225(9)
Authors: Yoshida, Daizo; Kim, Kyonsong; Noha, Masahiro; Teramoto, Akira

Pharmacokinetic study of BSH and BPA in simultaneous use for BNCT
pp. 227-232(6)
Authors: Yokoyama, Kunio; Miyatake, Shin-Ichi; Kajimoto, Yoshinaga; Kawabata, Shinji; Doi, Atsushi; Yoshida, Toshiko; Asano, Tomoyuki; Kirihata, Mitsunori; Ono, Koji; Kuroiwa, Toshihiko

Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas
pp. 233-247(15)
Authors: Jensen, Randy; Ragel, Brian; Whang, Kum; Gillespie, David

Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature
pp. 249-253(5)
Authors: Kan, Peter; Gottfried, Oren; Blumenthal, Deborah; Liu, James; Salzman, Karen; Townsend, Jeannette; Jensen, Randy

Systemic high-dose intravenous methotrexate for central nervous system metastases
pp. 255-260(6)
Authors: Lassman, Andrew; Abrey, Lauren; Shah, Gaurav; Panageas, Katherine; Begemann, Martin; Malkin, Mark; Raizer, Jeffrey

Systemic high-dose intravenous methotrexate for central nervous system metastases
pp. 261-261(1)
Authors: Lassman, Andrew; Abrey, Lauren; Shah, Gaurav; Panageas, Katherine; Begemann, Martin; Malkin, Mark; Raizer, Jeffrey

Chordoid Meningioma, an uncommon variant of meningioma: A clinicopathologic study of 12 cases
pp. 263-269(7)
Authors: Epari, S.; Sharma, M.; Sarkar, C.; Garg, A.; Gupta, A.; Mehta, V.

Salvage chemotherapy With CPT-11 for recurrent meningioma
pp. 271-276(6)
Authors: Chamberlain, Marc; Tsao-Wei, Denice; Groshen, Susan

Vinorelbine combined with a protracted course of temozolomide for recurrent brain Metastases: a phase I trial
pp. 277-280(4)
Authors: Omuro, A.M.; Raizer, J.J.; Demopoulos, A.; Malkin, M.G.; Abrey, L.E.

Mechanisms of angiogenesis in gliomas
pp. 281-293(13)
Authors: Kargiotis, O.; Rao, J.S.; Kyritsis, A.P.

Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation
pp. 295-302(8)
Authors: Levin, Victor; Phuphanich, Surasak; Alfred Yung, W.K.; Forsyth, Peter; Maestro, Rolando; Perry, James; Fuller, Gregory; Baillet, Mark

Intracranial tumors in adult population of the Varaždin County (Croatia) 1996-2004: a␣population-based retrospective incidence study
pp. 303-310(8)
Authors: Dobec-Meić, Biserka; Pikija, Slaven; Cvetko, Danijel; Trkulja, Vladimir; Pažanin, Leo; Kudelić, Nenad; Rotim, Krešimir; Pavliček, Ivan; Kostanjevec, and Ruža

A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma
pp. 311-316(6)
Authors: Tang, P.; Roldan, G.; Brasher, P.M.A; Fulton, D.; Roa, W.; Murtha, A.; Cairncross, J.G.; Forsyth, P.A.

Embryonal tumor with abundant neuropil and true rosettes. A new entity or only variations of a parent neoplasms (PNETs)? This is the dilemma
pp. 317-320(4)
Authors: Spina, M.; Pizzolitto, S.; Skrap, M.; Nocerino, A.; Russo, G.; Cataldo, A.; Perilongo, G.

High-grade astrocytoma treated concomitantly with estramustine and radiotherapy
pp. 321-326(6)
Authors: Henriksson, Roger; Malmström, Annika; Bergström, Per; Bergh, Gertrud; Trojanowski, Thomas; Andreasson, Lars; Blomquist, Erik; Jonsborg, Sonny; Edekling, Tomas; Salander, Pär; Brännström, Thomas; Bergenheim, A.

Addendum to “Aggressive spinal germinoma with ascending metastases”
pp. 327-327(1)
Authors: Tekkök, Ismail